최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기韓國家畜衛生學會誌 = Korean journal of veterinary service, v.42 no.2, 2019년, pp.53 - 60
김경미 (인천광역시보건환경연구원) , 조민행 (인천광역시보건환경연구원) , 이승환 (인천광역시보건환경연구원) , 김경호 (인천광역시보건환경연구원) , 이정구 (인천광역시보건환경연구원) , 이성모 (인천광역시보건환경연구원)
This study was performed to investigate antimicrobial resistance in bacterial isolates obtained from companion dogs in veterinary hospitals and an animal shelter in Incheon. Drug resistance was examined respectively with the isolates of Escherichia coli, Enterococcus faecalis, and Staphylococcus pse...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
E. coli가 항생제 내성 조사에 적합한 이유? | coli는 항생제에 항상 노출되어 있고 면역력이 약해졌을 때 질병을 일으키기도 하는 기회감염균이다. 또한 세균 간에 항생제 내성 유전자 이동이 가능하여 항생제 내성을 갖기도 용이함에 따라 항생제 내성 조사에 적합하다(Miller et al, 2004). 아울러 반려동물에서 분리한 대장균에서 항생제 내성 조사는 여러 차례 보고된 바가 있다(Carattoli et al, 2005; So et al, 2011). | |
국내의 2017년 기준 반려동물 보유가구 비율은? | 또한 최근 우리나라는 ‘반려동물 돌봄 가구 천만시대’ 라 불릴 만큼 주변에서 흔하게 반려동물을 접할수 있다. 농림축산검역본부의 2017년 동물보호에 대한 국민의식조사 보고서에 따르면 반려동물 보유가구 비율이 전체가구의 28.1%로 4가구 중 1가구는 반려동물을 기르는 것으로 나타났다. 이는 2015년 21. | |
반려동물 보유인구 증가가 동물병원 의료수준에 미친 영향은? | 반려동물 보유인구 증가만큼 국내 반려동물 관련 시장 규모의 성장에 따라 광범위 항생제 사용, 진료 서비스의 전문화 및 응급실 운영 등 동물병원에서의 의료수준도 향상되었다(Kang et al, 2009). 그러나 반려동물에 사용하는 항생제의 내성에 대한 관심은 미미한 실정이며, 이는 반려동물과 밀접하게 생활하고 있는 사람의 건강에 문제가 될 수 있음을 시사한다(Pitout et al, 2008). |
농림축산식품부. 2016. 축산 분야(반려동물포함) 항생제 내성 관리 계획.
농림축산검역본부. 2017. 2017년 동물보호에 대한 국민 의식 조사.
Bannoehr J, Guardadassi L. 2012. Staphylococcus pseudintermedius in the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicity. Vet Dermatol 23(4): 253-266.
Caprioli A, Busani L, Martel JL, Hemuth R. 2000. Monitoring of antibiotic resistance in bacteria of animal origin: epidemiological and microbiological methodologies. Int J Antmicrob Agents 14(4): 295-301.
Carattoli A, Lovari S, Franco A, Cordaro G, Matteo PD, Battisti A. 2005. Extended-Spectrum ${\beta}$ -Lactamases in Escherichia coli isolated from Dogs and Cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 49(2): 833-835.
Cho JK, Lee MR, Kim JM, Kim HD, 2016. Methicillin-resistant or susceptible staphylococcus pseudintermedius isolates from dogs and cats. Korean J Vet serv 39(3): 175-181.
Clinical and Laboratory Standards Institute(CLSI). 2017. Performance standards for antimicrobial susceptibility testing, Twenty-seven informational supplement, CLSI document M100-S27.
Cosgrove SE. 2006. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42(2): 82-89.
Devriese LA, Vancanneyt M, Baele M, De Graef E, Snauwaert C, Cleenwerck I, Dawyndt P, Swings J, Decostere A, Haesebrouck F. 2005. Staphylococcus pseudintermedisus sp. nov., a coagulase-positive species from animals. Int J Syst Evol Microbiol 55(4): 1569-1573.
Dziva F, Wint C, Auguste T, Heeraman C, Dacon C, Yu P, Koma LM. 2015. First identification of methicillin-resistant Staphylococcus pseudintermedius strains among coagulase-positive staphylococci isolated from dogs with otitis externa in Trinidad, West Indies. Infect Ecol Epidemiol 5(1): 29170 http://doi.org/10.3402/iee.v5.29170.
Kang DJ, Chung B.H, Heo J, Kang CB. 2009. Study on Companion Dog Practice and Management System on Animal Hospital in Seoul city. J Agri Life Sci 43(2): 39-46.
Kang MH, Chae MJ, Yoo JW, Kim SG, Lee SY, Yoo JH, Park HM. 2014. Antibiotic resistance and molecular characterization of ophthalmic Staphylococcus pseudintermedius isolates from dogs. J Vet Sci 15(3): 409-415.
Kloos WE. 1980. Natural populations of the genus Staphylococcus. Annu Rev Microbiol 34: 559-592.
Kwon KH, Hwang SY, Moon BY, Park YK, Shin S, Hwang CY, Park YH. 2012. Occurrence of antimicrobial resistance and virulence genes, and distribution of enterococcal clonal complex 17 from animals and human beings in Korea. J Vet Diagn Invest 24(5): 924-931.
Loeffler A, Linek M, Moodley A, Guardabassi L, Sung JM, Winkler M, Weiss R, Lloyd DH. 2007. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet Dermatol 18(6): 412-421.
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbath S, Hindler JF, Kahlmeter G, Olsson-Liljeuist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3): 268-281.
Miller k, O'Neill AJ, Chopra I. 2004. Escherichia coli Mutators Present an Enhanced Risk for Emergence of Antibiotic Resistance during Urinary Tract Infections. Antimicrob Agents Chemother 48(1): 23-29.
Murray BE. 1998. Diversity among multidrug-resistant enterococci. Emerg Infect Dis 4(1): 37-47.
Nam HM, Lee HS, Byun JW, Yoon SS, Jung SC, Joo YS, Lim SK. 2010. Prevalence of antimicrobial resistance in fecal Escherichia coli isolates from stray pet dogs and hospitalized pet dogs in korea. Microb Drug Resist 16(1): 75-79.
Oh YI, Kim HJ, Kim YM, Kim SS, Kim JK, Kim HW, Kang BJ, Youn HY. 2017. Antimicrobial Resistance of Bacterial Isolates from Positive Urine Culture in Four Hundred Five Dogs Between 2013-2014. Intern J Appl Res Vet Med 15(2): 99-107.
Pitout JD, Laupland KB. 2008. Extended-spectrum ${\beta}$ -lactamase - producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8(3): 159-166.
Platell JL, Cobbold RN, Johnson JR, Trott DJ. 2010. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J Antimicrob Chemother 65(9): 1936-1938.
Sava IG, Heikens E, Huebner J. 2010. Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect 16(6): 533-540.
So JH, Kim J, Bae IK, Jeong SH, Kim SH, Lim SK, Park YH, Lee K. 2012. Dissemination of multidrug-resistant Escherichia coli in Korean veterinary hospitals. Diagn Microbiol Infect Dis 73(2): 195-199.
Talan DA, Staatz D, Staatz A, Goldstein EJ, Singer K, Overturf GD. 1989. Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol 27(1): 78-81.
Tuerena I, Willimas NJ, Nuttall T, Pinchbeck G. 2016. Antimicrobial-resistant Escherichia coli in hospitalised companion animals and their hospital environment. J Small Anim Pract 57(7): 339-347.
van Duijkeren E, Catry B, Greko C, Moreno MA. 2011. Review on methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother 66(12): 2705-2714.
Weese JS. 2008. Issues regarding the use of vancomycin in companion animals. J Am Vet Med Assoc 233(4): 565-567.
Weese JS, van Duijkeren E. 2010. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol 140(3-4): 418-429.
Yazgi H, Ertek M, Erol S, Ayyildiz A. 2002. A comparison of high-level aminoglycoside resistance in vancomycin-sensitive and vancomycin-resistant Enterococcus species. J Int Med Res 30(5): 529-534.
Yoon YK, Sim HS, Kim JY, Park DW, Sohn JW, Roh KH, Lee SE, Kim MJ. 2009. Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units. Yonsei Med J 50(5): 637-643.
Zubeir IE, Kanbar T, Alber J, Lammler C, Akineden O, Weiss R, Zschock M. 2007. Phenotypic and genotypic characteristics of methicillin/oxacillin-resistant Staphylococcus intermedius isolated from clinical specimens during routine veterinary microbiological examinations. Vet Microbiol 12l(1-2): 170-176.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.